SXTC China SXT Pharmaceuticals, Inc.

Fundamentals / CIK 0001723980 / USD

China SXT Pharmaceuticals, Inc. reported $1.14M in revenue and a net loss of $6.21M for the fiscal year ended March 31, 2026 (down 34.6% year over year), with a 21.9% gross margin and a -625.9% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open SXTC in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2017 to 2026), reported in USD.

$8.00M$4.00M$0-$10.22MFY 2017 Revenue: $4.88MFY 2017 Net Income: $1.19M2017FY 2018 Revenue: $7.02MFY 2018 Net Income: $1.19M2018FY 2019 Revenue: $7.01MFY 2019 Net Income: $1.54M2019FY 2020 Revenue: $5.16MFY 2020 Net Income: -$10.29M2020FY 2021 Revenue: $4.78MFY 2021 Net Income: -$2.75M2021FY 2022 Revenue: $2.60MFY 2022 Net Income: -$5.74M2022FY 2023 Revenue: $1.97MFY 2023 Net Income: -$5.93M2023FY 2024 Revenue: $1.93MFY 2024 Net Income: -$3.10M2024FY 2025 Revenue: $1.74MFY 2025 Net Income: -$3.30M2025FY 2026 Revenue: $1.14MFY 2026 Net Income: -$6.21M2026

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31
Revenue $1.14M $1.74M $1.93M $1.97M $2.60M $4.78M $5.16M $7.01M $7.02M $4.88M
Cost of Revenue $889K $1.37M $1.37M $1.55M $1.35M $1.94M $2.46M $2.40M $3.62M $2.57M
Gross Profit $249K $367K $554K $426K $1.25M $2.84M $2.70M $4.61M $3.40M $2.31M
Research & Development -- -- $184K $201K $367K -- -- -- -- --
Selling, General & Admin $7.37M $3.05M $3.07M $6.03M $6.44M $5.04M $4.04M $2.84M $1.77M $710K
Total Operating Expenses $7.37M $3.05M $3.07M $6.03M $6.44M $5.04M $4.04M $2.84M $1.77M $710K
Operating Income -$7.12M -$2.68M -$2.52M -$5.61M -$5.19M -$2.20M -$1.34M $1.77M $1.63M $1.60M
EBITDA -$7.05M -$2.60M -$2.31M -$5.36M -$4.87M -$1.85M -$1.01M $1.95M $1.76M $1.70M
Interest Expense $63K $648K $544K $477K $37K $1.62M $3.35M $5.2K $779 $40K
Income Before Tax -$6.21M -$3.30M -$3.10M -$5.93M -$5.41M -$2.94M -$10.39M $1.79M $1.63M $1.58M
Income Tax Expense -- -- -- -- $328K -$193K -$102K $252K $440K $395K
Net Income -$6.21M -$3.30M -$3.10M -$5.93M -$5.74M -$2.75M -$10.29M $1.54M $1.19M $1.19M
Basic EPS -$9.13 -$348.17 -$4,285.66 -$26,542.84 -$164,678.21 -$114,000.00 $993,492.54 $2,238.81 $1,761.19 $1,761.19
Diluted EPS -$9.13 -$348.17 -$4,285.66 -$26,542.84 -$164,678.21 -$114,000.00 $49,671.64 $2,238.81 $1,761.19 $1,761.19
Basic Shares Outstanding 679.6K 9.5K 723 224 35 24 10 689 670 670
Diluted Shares Outstanding 679.6K 9.5K 723 224 35 24 207 689 670 670

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

No quarterly income statement rows are available in SEC EDGAR CompanyFacts for SXTC.

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31
Cash & Cash Equivalents $28.18M $18.10M $12.07M $17.37M $77K $13.36M $7.29M $9.29M $658K
Cash & Short-Term Investments $28.18M $18.10M $12.07M $17.37M $77K $13.36M $7.29M $9.29M $658K
Accounts Receivable, Net $932K $1.30M $1.31M $1.34M $3.33M $4.51M $3.82M $4.18M $2.60M
Inventory $777K $828K $795K $531K $1.02M $860K $893K $1.01M $1.27M
Total Current Assets $34.51M $21.30M $14.23M $19.52M $22.45M $23.23M $19.64M $15.59M $6.10M
Property, Plant & Equipment, Net $117K $179K $329K $962K $1.23M $1.43M $1.57M $1.16M $862K
Intangible Assets $6.3K $12K $19K $28K $39K $46K $50K $61K $61K
Total Non-Current Assets $245K $367K $8.89M $10.03M $11.09M $11.31M $2.07M $1.88M $1.56M
Total Assets $34.75M $21.66M $23.13M $29.55M $33.55M $34.55M $21.70M $17.47M $7.66M
Accounts Payable $498K $1.16M $1.28M $1.38M $1.48M $1.46M $1.94M $1.69M $2.41M
Short-Term Debt $355K $711K $514K $175K $23K $37K $44K $28K --
Deferred Revenue (Current) $104K $59K $188K $166K -- -- -- -- --
Other Current Liabilities -- -- -- $789K $1.16M $820K $288K $165K $147K
Total Current Liabilities $4.35M $6.01M $8.90M $14.50M $17.12M $18.58M $12.26M $6.32M $4.37M
Long-Term Debt $644K $96K $117K $118K -- -- -- -- --
Total Non-Current Liabilities $698K $212K $295K $366K $0 $6.3K $37K $42K $0
Total Liabilities $5.05M $6.22M $9.20M $14.86M $17.12M $18.59M $12.30M $6.36M $4.37M
Total Debt (incl. Leases) $1.12M $984K $867K $599K $23K $37K $44K $28K --
Common Stock $64.13M $44.53M $39.67M $914K $162K $62K $35K $23K $20K
Retained Earnings -$34.22M -$28.02M -$24.71M -$21.61M -$15.69M -$9.95M -$7.20M $3.08M $1.54M
Accumulated Other Comp. Income -$198K -$1.08M -$1.03M -$198K $956K $528K -$591K $50K $257K
Total Stockholders' Equity $29.71M $15.44M $13.93M $14.69M $16.08M $15.96M $9.40M $11.11M $3.29M
Total Equity $29.71M $15.44M $13.93M $14.69M $16.08M $15.96M $9.40M $11.11M $3.29M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Cash & Cash Equivalents $28.18M $18.10M $12.07M $17.37M $77K $13.36M $7.29M $9.29M
Cash & Short-Term Investments $28.18M $18.10M $12.07M $17.37M $77K $13.36M $7.29M $9.29M
Accounts Receivable, Net $932K $1.30M $1.31M $1.34M $3.33M $4.51M $3.82M $4.18M
Inventory $777K $828K $795K $531K $1.02M $860K $893K $1.01M
Total Current Assets $34.51M $21.30M $14.23M $19.52M $22.45M $23.23M $19.64M $15.59M
Property, Plant & Equipment, Net $117K $179K $329K $962K $1.23M $1.43M $1.57M $1.16M
Intangible Assets $6.3K $12K $19K $28K $39K $46K $50K $61K
Total Non-Current Assets $245K $367K $8.89M $10.03M $11.09M $11.31M $2.07M $1.88M
Total Assets $34.75M $21.66M $23.13M $29.55M $33.55M $34.55M $21.70M $17.47M
Accounts Payable $498K $1.16M $1.28M $1.38M $1.48M $1.46M $1.94M $1.69M
Short-Term Debt $355K $711K $514K $175K $23K $37K $44K $28K
Deferred Revenue (Current) $104K $59K $188K $166K -- -- -- --
Other Current Liabilities -- -- -- $789K $1.16M $820K $288K $165K
Total Current Liabilities $4.35M $6.01M $8.90M $14.50M $17.12M $18.58M $12.26M $6.32M
Long-Term Debt $644K $96K $117K $118K -- -- -- --
Total Non-Current Liabilities $698K $212K $295K $366K $0 $6.3K $37K $42K
Total Liabilities $5.05M $6.22M $9.20M $14.86M $17.12M $18.59M $12.30M $6.36M
Total Debt (incl. Leases) $1.12M $984K $867K $599K $23K $37K $44K $28K
Common Stock $64.13M $44.53M $39.67M $914K $162K $62K $35K $23K
Retained Earnings -$34.22M -$28.02M -$24.71M -$21.61M -$15.69M -$9.95M -$7.20M $3.08M
Accumulated Other Comp. Income -$198K -$1.08M -$1.03M -$198K $956K $528K -$591K $50K
Total Stockholders' Equity $29.71M $15.44M $13.93M $14.69M $16.08M $15.96M $9.40M $11.11M
Total Equity $29.71M $15.44M $13.93M $14.69M $16.08M $15.96M $9.40M $11.11M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31
Net Income -$6.21M -$3.30M -$3.10M -$5.93M -$5.74M -$2.75M -$10.29M $1.54M $1.19M $1.19M
Depreciation & Amortization $74K $82K $203K $250K $320K $345K $332K $181K $129K $99K
Stock-Based Compensation $5.31M -- $352K $555K $2.33M -- -- -- -- --
Change in Receivables $291K -$257K -$321K $913K $831K -$519K $104K -$1.81M $384K -$943K
Change in Inventory $36K -$15K -$220K $409K -$181K $39K $40K $155K -$274K $384K
Change in Payables -$693K -$114K -$29K $9.7K -$23K -- $302K -$567K $967K -$1.47M
Operating Cash Flow -$4.02M -$2.35M -$1.93M -$81K $268K -$1.32M $934K $239K $1.92M $293K
Capital Expenditure -- -$2.0K -$7.1K -- -$61K -$78K -$131K -$536K -$436K -$179K
Free Cash Flow -- -$2.35M -$1.94M -- $207K -$1.39M $803K -$297K $1.48M $114K
Investing Cash Flow -$1.25M $64K $26K -$12K -$47K -$5.81M -$5.50M -$610K -$1.05M -$186K
Common Stock Issued -- -- -- -- -$30K -- -- -- -- --
Financing Cash Flow $14.43M $8.40M -$2.62M $2.94M $1.60M $12.41M $3.02M $9.04M -$314K -$51K
Net Change in Cash $10.05M $6.05M -$5.29M $1.80M $2.21M $6.07M -$2.00M $8.63M $592K $54K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

No quarterly cash flow statement rows are available in SEC EDGAR CompanyFacts for SXTC.

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31
Gross Margin 21.9% 21.1% 28.7% 21.6% 48.1% 59.4% 52.4% 65.8% 48.5% 47.4%
Operating Margin -625.9% -154.0% -130.4% -284.4% -199.4% -46.0% -26.0% 25.2% 23.3% 32.8%
Net Profit Margin -545.2% -189.8% -160.7% -301.0% -220.4% -57.5% -199.3% 22.0% 16.9% 24.3%
Return on Equity (ROE) -20.9% -21.4% -22.2% -40.4% -35.7% -17.2% -109.4% 13.9% 36.1% --
Return on Assets (ROA) -17.9% -15.2% -13.4% -20.1% -17.1% -8.0% -47.4% 8.8% 15.5% --
Current Ratio 7.93x 3.54x 1.60x 1.35x 1.31x 1.25x 1.60x 2.47x 1.40x --
Quick Ratio 7.76x 3.40x 1.51x 1.31x 1.25x 1.20x 1.53x 2.31x 1.11x --
Debt to Equity 0.04x 0.06x 0.06x 0.04x 0.00x 0.00x 0.00x 0.00x -- --
Revenue Growth (YoY) -34.6% -9.7% -2.2% -24.2% -45.5% -7.5% -26.4% -0.1% +43.8% --
Gross Profit Growth (YoY) -32.3% -33.7% +30.0% -65.9% -55.9% +5.0% -41.4% +35.6% +47.1% --
Operating Income Growth (YoY) -- -- -- -- -- -- -175.8% +8.4% +1.9% --
Net Income Growth (YoY) -- -- -- -- -- -- -768.4% +29.6% +0.2% --
EPS Growth (YoY) -- -- -- -- -- -111.5% +44276.0% +27.1% 0.0% --
Operating Cash Flow Growth (YoY) -- -- -- -130.1% -- -240.9% +290.6% -87.5% +555.3% --
Free Cash Flow Growth (YoY) -- -- -- -- -- -273.6% -- -120.0% +1203.4% --
5Y Revenue / Share Growth -100.0% -100.0% -73.8% -16.0% +920.5% -- -- -- -- --
5Y Net Income / Share Growth -- -- -291.8% -1594.7% -9365.1% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

No quarterly ratios & growth rows are available in SEC EDGAR CompanyFacts for SXTC.
Source: SEC EDGAR CompanyFacts (CIK 0001723980) · from March 31, 2017 Data through March 31, 2026 · synced Nov 21, 2026, 05:16 UTC · Open in terminal